A recent study published in JAMA Surgery found that the attrition rate among general surgery residents was lower than previously thought, with only 8.8% leaving their training programs compared to 20%. The study also identified a significant difference in program directors' attitudes and support for struggling residents between high- a...
The National Institutes of Health (NIH) has awarded a grant to advance emergency care in Southern California. The Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN), led by LA BioMed, aims to conduct large-scale clinical trials to improve patient outcomes for cardiac arrest, trauma, and other medical emergencies.
A recent study from LA BioMed researchers found that the proper use of acupuncture can lead to elevated levels of nitric oxide in the skin at acupoints, increasing blood flow and analgesic release. The study suggests that this method may contribute to the pain-relieving effects of acupuncture.
Dr. Jack Edwards, a leading researcher at LA BioMed, has been recognized with the Rhoda Benham Award for his continuous outstanding contributions to medical mycology. His work focuses on understanding fungal diseases, aiming to develop new anti-fungal agents and immunotherapies to prevent life-threatening infections.
Dr. French is recognized for his groundbreaking research and extensive writing about alcoholic liver disease, totaling over 450 peer-reviewed papers and 19,470 citations.
A new study published in JAMA suggests that testosterone treatments may increase the risk of heart disease in older men. The study found a significant increase in arterial plaque among men aged 65 and older who received testosterone replacement therapy for a year, with a 20% rise in total coronary and noncalcified plaque volumes.
Research found testosterone treatment improved bone density and anemia for men over 65 with low testosterone, while also increasing plaque buildup in coronary arteries. However, cognitive function remained unchanged.
A study by LA BioMed and UCLA researchers found that over 50% of hospital ICU admissions could have been cared for in less expensive settings. Nearly 65% of ICU days were allocated to discretionary monitoring, which is not necessary for patients who are too well or too sick.
Researchers at LA BioMed have discovered a low-cost eye drop solution that is equally effective to expensive antibiotics in treating bacterial keratitis. The povidone-iodine solution has the potential to save thousands of lives by preventing blindness in developing countries.
A new study from LA BioMed found that lower-income minority patients and healthcare providers have markedly divergent perceptions of the barriers to diabetic retinopathy screening. Patients reported financial burden and depression as major obstacles, while providers deemed other factors more significant.
A new study found that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-II receptor blockers (ARB) have similar results in reducing cardiovascular events in patients on peritoneal dialysis. The researchers surveyed records of Medicare Part D patients and found no significant difference between the two medication classes.
A new study by LA BioMed and UCLA found that hospitals using ICUs more frequently perform more costly and invasive procedures but do not see better mortality rates among patients with four common conditions. The study analyzed records from 156,842 hospitalizations and reported higher costs ranging from $647 to $3,412.
Researchers have identified molecular pathways required for the development of mucormycosis, a fatal infection in patients with weakened immune systems. The study provides new insights into the evolution of Mucorales fungi and offers potential therapeutic targets.
A new study found that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) can reduce the risk of strokes, heart attacks, and death in patients with end-stage renal disease undergoing peritoneal dialysis. The study involved 4,879 patients and showed a 16% lower risk of cardiovascular events with...
LA BioMed researchers find a new study on aromatase inhibitors to prevent breast cancer recurrence is reassuring. The study's findings have direct application for clinical practice, with implications for cardiologists and oncologists.
Researchers at Phoenix Nest and LA BioMed are working on developing therapies for treating different forms of Sanfilippo disease, a progressive neurological disorder that affects children. The new grants will focus on recombinant enzyme therapy and stem cell treatment to combat devastating brain damage caused by MPS IIID and MPS IIIB.
A new study suggests that sodium bicarbonate can reverse the effects of mucormycosis-promoting processes in DKA, a life-threatening condition. The researchers identified key host factors and fungal cell surface proteins that enhance infection and damage.
A low-fat diet for eight years improved breast cancer survival rates and reduced mortality in postmenopausal women. The study, conducted by the Women's Health Initiative, found that a sustained low-fat diet increased survival rates among women diagnosed with breast cancer.
A study published in Antimicrobial Agents and Chemotherapy found that patients with S. aureus skin and soft tissue infections took only 57% of their prescribed antibiotic doses after leaving the hospital. This led to nearly half of them getting a new infection or requiring additional treatment.
A new study developed a unique formula to predict the potential for cognitive deficits in former professional football players. The formula combines concussion severity, frequency, game-related data, and mental abilities, revealing that a strong cognitive reserve is the most important factor.
The TTrials study reveals that testosterone treatment improves sexual function, including increased sexual activity and desire, as well as walking ability and mood. However, the treatment did not significantly improve energy or cognitive function, and its risks remain unclear.
A new report identifies several forms of testing to measure the risk of heart disease in patients with type 2 diabetes. These tests include exercise testing and coronary calcium scanning, which can detect silent ischemia and identify the highest-risk patients for more effective treatments. The study suggests that a significant proporti...
Researchers found Aged Garlic Extract slows total plaque accumulation by 80% and reduces soft plaque in patients with metabolic syndrome. The study reversed deadly plaque buildup in arteries, a potential breakthrough in treating heart disease.
A new study found that prenatal methamphetamine exposure can lead to targeted behavioral issues, but a supportive home environment significantly decreases their severity. The study surveyed 290 children and found strong relations between prenatal methamphetamine exposure and rule-breaking behavior.
Dr. John Michael Criley receives the 2016 Distinguished Teacher Award for his innovative and compassionate teaching, training over 2,200 cardiologists and medical professionals worldwide. He has made significant contributions to cardiovascular medicine through his research papers and textbooks.
A study by LA BioMed suggests that involving parents in violence prevention programs and tailoring them to specific racial/ethnic groups can improve their effectiveness. The research found that Latino parents condoned fighting only as a last resort, while African American parents sometimes saw it as necessary.
A recent study published in Endocrinology Today holds promise for cancer patients undergoing chemotherapy to protect their fertility and defense systems. Researchers found that the potent humanin analogue (HNG) protected male germ cells and white blood cells, reducing infertility and infection susceptibility.
The LA BioMed's Catalina Island Clinic has received a $10,000 grant to provide confidential, free, and no-cost reproductive health care services to uninsured women and adolescent girls. The clinic offers a range of services, including family planning, STI testing, and counseling.
Dr. Ronald Oudiz, a renowned researcher at LA BioMed, is being recognized for his pioneering work in the pulmonary hypertension field. His contributions have led to significant advancements in understanding and treating this potentially fatal disease.
A LA BioMed researcher is launching a study of medication adherence among dialysis patients, aiming to improve patient health outcomes. The researcher will examine the factors contributing to non-adherence and its impact on cardiovascular disease risk.
A new study reports that bathing patients in chlorhexidine was equally effective in preventing MRSA transmission as current contact precautions, reducing contamination events by 29%. The research challenges the practice of limiting patient contact and may provide a cheaper alternative strategy for improving patient care.
A multicenter clinical trial found that clindamycin and trimethoprim sulfamethoxazole (TMP-SMX) are similarly effective in treating uncomplicated skin infections, with cure rates of 80.3% and 77.7%, respectively. The study was conducted on 524 adults and children with cellulitis or abscesses.
A new study has identified protein modification needed to treat IBMPFD, a rare and deadly genetic disorder. The researchers found that changing the p47 protein could lead to proper cellular functions in cells with mutated p97, opening the door for potential treatments or prevention.
A new grant will fund research to develop a rapid diagnosis for mucormycosis, a rare fungal infection that kills more than half of its victims. The project aims to create a quick and accurate test to help physicians treat the infection promptly.
A study found that most teens and young adults with type 1 diabetes are interested in a peer mentoring program to improve diabetes control, despite social barriers. The researchers also found that those with supportive friends and family members were more likely to be interested.
A new LA BioMed study found that platelet transfusions and DDAVP are not effective in preventing further bleeding or death in patients with traumatic brain injuries. The researchers analyzed data from 408 patients and found no significant differences in mortality or hemorrhage progression between those who received the treatments and t...
Researchers at LA BioMed have developed a novel vaccine, NDV-3, that can protect against methicillin-resistant Staphylococcus aureus (MRSA) skin infections. The vaccine enhances molecular and cellular immune defenses of the skin in response to MRSA and other S. aureus bacteria.
LA BioMed researcher Frans J. Walther is receiving Phase II funding to develop an aerosol form of synthetic lung surfactant, which could reduce complications in premature babies. The grant will support the development of a new treatment that can be easily administered in resource-limited settings.
A new ECG device, QTScreen, has the potential to identify infants at risk of long QT syndrome, a genetic heart condition that can be treated with medication. The device will be tested on 4,000 babies in Southern California and is designed to be easy to use for parents.
Researchers are working to develop a therapy for Sanfilippo disease, a devastating inherited disorder that affects the brain. The $223,102 grant will be used to create an enzyme replacement therapy to treat the underlying causes of the neurologic symptoms of MPS III.
Researchers found that universal MRSA screening and isolation can prevent nearly three hospital-acquired MRSA infections but come with a high cost. Targeted screenings for high-risk patients also showed limited success in preventing infections while resulting in financial losses.
A study published by LA BioMed researchers found that patients who tested positive for THC in their system had a lower mortality rate than those who didn't, with only 2.4% of THC-positive patients dying compared to 11.5% of THC-negative patients. The researchers suggest that THC may help protect the brain after traumatic injury.
Scientists at LA BioMed have discovered a way to bypass the blood-brain barrier and deliver an enzyme replacement therapy to treat MPS IIIB, a devastating genetic disease. The treatment has shown promising results by reducing the accumulation of waste products in brain cells.
Researchers found that patients undergoing laparoscopic cholecystectomy during normal working hours were more likely to receive minimally invasive procedures. The study also revealed no significant differences in complication rates or length of stay between day and night surgeries.
Researchers at LA BioMed are developing a vaccine to protect patients from healthcare-related infections such as Candida and MRSA. The NIH grant will support the study of samples from patients enrolled in an ongoing clinical trial to assess the efficacy of the vaccine.
Dr. Rowan Chlebowski, a leading expert in women's health, has been recognized by the North American Menopause Society for his groundbreaking research on estrogen alone and joint symptoms. His work has significantly impacted clinical use of menopausal hormone therapy worldwide.
Dr. Richard Casaburi will receive the Distinguished Scientist Honor Lecturer award from CHEST, recognizing his pioneering work in developing rehabilitative treatments for COPD. He leads LA BioMed's pulmonary rehabilitation research and has received numerous awards for his contributions.
The LA BioMed project aims to develop integrated and comprehensive care models to help Centinela Valley residents manage their diabetes. The goal is to prevent long-term complications such as kidney failure, amputations, and blindness.
A new study found significant variation in MRSA rates among five US cities, with Los Angeles experiencing a 57% decline and New York tripling its rates. The study suggests that bacterial ecology is changing fundamentally, requiring further research to protect public health.
A recent study published in Metabolomics found that EGCG, a green tea extract, disrupts the balance of metabolic pathways in pancreatic cancer cells, reducing their growth and increasing the risk of cancer. Researchers also identified an enzyme inhibitor, oxamate, which operates in a similar manner.